Obstructive Laryngitis Treatment Market size is expected to reach USD 3.6 Billion by the end of 2036, growing at a CAGR of 5% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of the obstructive laryngitis treatment was over USD 2 Billion. The increasing prevalence of laryngeal disorders, such as vocal cord paralysis, vocal fold lesions, and laryngeal cancers, is a significant growth driver for the market. As per recent estimates, 12,380 new instances of laryngeal cancer are estimated, with 2,480 women and 9,900 males affected. On the other hand, factors like aging populations, changing lifestyles, and environmental factors contribute to the surge in these conditions. As the incidence of such disorders rises, the demand for effective treatment options, driving market growth, becomes more pronounced, shaping the landscape for laryngeal treatments.
As Awareness Grows and diagnostics Capabilities improve, there’s a heightened need for advanced therapeutic solutions, propelling market expansion for obstructive laryngitis treatments.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
~ 5% |
|
Base Year Market Size (2023) |
~ USD 2 Billion |
|
Forecast Year Market Size (2036) |
~ USD 3.6 Billion |
|
Regional Scope
|
|
Medication (Glucocorticoid, Dexamethasone, Epinephrine)
The glucocorticoid segment is estimated to hold 52% share of the global obstructive laryngitis treatment market by 2036. Systemic corticosteroid reduces laryngeal edema by reducing local inflammatory responses, contracting lymphocyte inflammation, and limiting capillary permeability. They were one of the main pillars of treatment in patients with croup due to their potent anti-inflammatory effect. It is believed that the anti-inflammatory qualities of glucocorticoids lessen edema and inflammation, which requires less effort from the youngster when breathing. A 2018 Cochrane Review that was updated found that glucocorticoids (prednisone, dexamethasone) shortened hospital stays, decreased the frequency of patient care follow-up visits, and alleviated croup symptoms in two hours. Within six hours of delivery, glucocorticoids were found to lessen the symptoms of croup, according to the earlier version of the Cochrane Review. Research has demonstrated that administering a single dosage of dexamethasone during the initial 4-24 hours post-illness start can lessen the overall severity of croup.
Drug Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
The hospital pharmacy segment in the obstructive laryngitis treatment market is anticipated to hold a significant revenue during the forecast period. The rise in the construction of hospitals backed by increased healthcare expenditure propels the segment’s demand. Further, the wide stock of drugs, therapies, and medical procedures provided by the hospitals is expected to increase the segment’s demand in the upcoming years.
Our in-depth analysis of the global market includes the following segments:
|
Medication |
|
|
Drug Distribution Channel |
|
North American Market Forecast
North American region obstructive laryngitis treatment market is expected to hold 45% of the revenue share by 2036. In the region, the market demonstrates a robust landscape driven by several influential factors. Technological advancements in medical procedures and equipment propel the market’s growth, offering innovative solutions such as laser surgeries, endoscopic interventions, and robotic-assisted treatments. This region’s healthcare infrastructure, coupled with a strong emphasis on research and development, fosters the adoption of cutting-edge therapies for laryngeal disorders. The increasing prevalence of conditions like laryngeal cancer and vocal cord paralysis fuels the demand for effective treatments. Moreover, a growing aging population susceptible to laryngeal ailments contributes to the market expansion.
Asia Pacific Market Statistics
Asia Pacific Market for obstructive laryngitis treatment is estimated to hold significant market value. The region showcases dynamic growth prospects driven by several key factors. The region’s burgeoning population, coupled with lifestyle changes, contributes to an increasing incidence of laryngeal disorders. Advancements in healthcare infrastructure and the adoption of cutting-edge technologies, especially in countries like Japan, South Korea, China, and India, propel the market forward. Rising healthcare expenditure and a growing focus on research and development activities for innovative treatment modalities further augment market expansion.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?